EDGAR Filing Documents for 9999999995-17-003253

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-17-003253

Accepted

2017-12-20 00:15:10

Documents

Effectiveness Date

2017-12-19

Registration Form

F-1

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	588
	Complete submission text file	9999999995-17-003253.txt		1696

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)